policy

Presentation to ACIP on recommending higher-dose and adjuvanted seasonal influenza vaccines for adults 65+

Work presented to the Advisory Committee on Immunization Practices (ACIP) that modeled the potential impact of recommending high-dose, adjuvanted and recombinant vaccines to adults aged 65 and over on seasonal influenza burden in the United States.